pyrrolidine-2,4-dicarboxylic acid has been researched along with Parkinsonian Disorders in 1 studies
pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assous, M | 1 |
| Had-Aissouni, L | 1 |
| Gubellini, P | 1 |
| Melon, C | 1 |
| Nafia, I | 1 |
| Salin, P | 1 |
| Kerkerian-Le-Goff, L | 1 |
| Kachidian, P | 1 |
1 other study available for pyrrolidine-2,4-dicarboxylic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra.
Topics: Acetylcysteine; Action Potentials; Animals; Dicarboxylic Acids; Disease Models, Animal; Exploratory | 2014 |